Speaker
Senior Principal, Regenerative Medicine, Dark Horse Consulting Group
Susan Drapeau, Senior Principal, Regenerative Medicine at Dark Horse Consulting Group, spoke at 8th Exosome-Based Therapeutics Development Summit (Boston, United States of America, 22–24 Sept 2026) in the session “When Will Big Pharma Join the EV Party?”.
22–24 Sept 2026Boston, United States of America
Chief Technology Officer, Gefjon Pharma
Research & Development Director, Neucore Bio
Hemato-Oncologist, Centro Oncologico de Antioquia
Chief Commercial Officer, NorthX Biologics
Chief Executive Officer, Aegle Therapeutics
R&D Director, NurExone
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Susan Drapeau, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].